CT26 colon-cancer Liver metastasis Peri-operative period Propranolol Etodolac b-Adrenergic blocker COX-2 inhibition Colorectal cancer a b s t r a c t Liver metastases are a major cause of colorectal cancer death, and the perioperative period is believed to critically affect the metastatic process. Here we tested whether blocking excess release of catecholamines and prostaglandins during surgical procedures of different extent can reduce experimental liver metastasis of the syngeneic CT26 colon cancer in female and male BALB/c mice. Animals were either treated with the beta-blocker, propranolol, the COX-2 inhibitor, etodolac, both drugs, or vehicle. The role of NK cells in controlling CT26 hepatic metastasis and in mediating the effect of the drugs was assessed by in vivo depletion or stimulation of NK cells, using anti-asialo GM1 or CpG-C, respectively. Surgical extent was manipulated by adding laparotomy to small incision, extending surgical duration, and enabling hypothermia. The results indicated that combined administration of propranolol and etodolac, but neither drug alone, significantly improved host resistance to metastasis. These beneficial effects occurred in both minor and extensive surgeries, in both sexes, and in two tumor inoculation approaches. NK cell-mediated anti-CT26 activity is involved in mediating the beneficial effects of the drugs. Specifically, CpG-C treatment, known to profoundly activate mice marginating-hepatic NK cytotoxicity, reduced CT26 hepatic metastases; and NK-depletion increased metastases and prevented the beneficial effects of the drugs. Overall, given prevalent perioperative psychological and physiological stress responses in patients, and ample prostaglandin release by colorectal tumors and injured tissue, propranolol and etodolac could be tested clinically in laparoscopic and open colorectal surgeries, attempting to reduce patients' metastatic disease.
Introduction
For decades, surgeries for the excision of primary tumors have been suggested to facilitate the metastatic process, and specific mechanisms mediating deleterious effects of surgery are continuously being unraveled. For example, the surgical manipulation of the malignant tissue and the surrounding blood vessels may disperse tumor cells into the circulation (Eschwege et al., 1995; Yamaguchi et al., 2000) , and may induce the release of growth factors by the host, aiming at tissue healing. These processes are believed to promote the initiation of new metastases and the development of pre-existing micrometastases (Fisher et al., 1989; Demicheli et al., 2001; Weitz and Herfarth, 2001 ). An additional factor is surgery-induced suppression of anti-metastatic cell mediated immunity (CMI) (Ben-Eliyahu, 2003) . Such suppression may render the organism susceptible to metastatic progression during the perioperative period, a timeframe which is believed to be critical in determining whether metastatic disease will be arrested or will progress (Shakhar and Ben-Eliyahu, 2003; Neeman and Ben-Eliyahu, 2013; Horowitz et al., 2015) . Natural killer cell cytotoxicity (NKCC) is an important aspect of innate immunity. NK cells secrete several prominent pro-CMI cytokines, and exhibit cytotoxicity against a variety of tumor cells, including those that escape adaptive immunity through the elimination of MHC-I molecules (Srivastava et al., 2008; Terunuma et al., 2008) .
Surgical procedures were shown to suppress CMI, including NKCC, through various mechanisms, and markedly through access perioperative release of catecholamines (CAs), prostaglandins (PGs), and glucocorticoids (GC) (Shakhar and Ben-Eliyahu, 1998, 2003; Shakhar and Blumenfeld, 2003; Benish et al., 2008; Rosenne et al., 2014) . The levels of these hormones increase during the perioperative period as a result of tissue damage, surgical stress responses, and in humans also by psychological distress (Neeman et al., 2012) . These immunosuppressive effects were associated or causally linked to a more profound metastatic progression and a greater mortality rate in animal models (Yakar et al., 2003;  
